
Vivos Therapeutics VVOS
$ 0.57
-3.36%
Quarterly report 2026-Q1
added 05-20-2026
Vivos Therapeutics Cash and Cash Equivalents 2011-2026 | VVOS
Annual Cash and Cash Equivalents Vivos Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.03 M | 6.26 M | 1.64 M | 3.52 M | 24 M | 18.2 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24 M | 1.64 M | 9.28 M |
Quarterly Cash and Cash Equivalents Vivos Therapeutics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.11 M | 3.09 M | 4.4 M | 2.34 M | 6.26 M | 6.31 M | 6.9 M | 2.61 M | 1.64 M | 988 K | 3.94 M | 200 K | 3.52 M | 6.72 M | 12.7 M | 17.8 M | 24 M | 28.5 M | 24 M | 14.1 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 469 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 28.5 M | 200 K | 9.82 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
105 M | - | - | $ 3.31 B | ||
|
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
45.9 M | $ 11.0 | -1.79 % | $ 311 M | ||
|
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
161 M | $ 8.07 | -2.12 % | $ 1.21 B | ||
|
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
29.8 M | $ 4.25 | - | $ 159 M | ||
|
BioSig Technologies
BSGM
|
20.3 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
13 M | $ 5.92 | 0.68 % | $ 70.8 M | ||
|
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
7.28 M | $ 2.3 | -0.43 % | $ 50.7 M | ||
|
MiMedx Group
MDXG
|
166 M | $ 3.67 | -3.17 % | $ 542 M | ||
|
Cytosorbents Corporation
CTSO
|
6.25 M | $ 0.46 | -2.11 % | $ 28.6 M | ||
|
OrthoPediatrics Corp.
KIDS
|
19.6 M | $ 18.3 | -1.08 % | $ 429 M | ||
|
LivaNova PLC
LIVN
|
636 M | $ 72.11 | -2.16 % | $ 3.93 B | ||
|
Delcath Systems
DCTH
|
43.5 M | $ 11.08 | -1.34 % | $ 397 M | ||
|
Profound Medical Corp.
PROF
|
59.7 M | $ 6.92 | - | $ 209 M | ||
|
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
6.03 M | $ 1.03 | 3.0 % | $ 17.4 M | ||
|
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
101 M | - | - | $ 10.2 M | ||
|
Pulmonx Corporation
LUNG
|
69.8 M | $ 1.47 | -4.55 % | $ 59.8 M | ||
|
Electromed
ELMD
|
15.3 M | $ 36.73 | -2.86 % | $ 311 M | ||
|
Myomo
MYO
|
14.1 M | $ 0.9 | -1.04 % | $ 37.7 M | ||
|
Butterfly Network
BFLY
|
150 M | $ 4.3 | -2.16 % | $ 1.06 B | ||
|
Second Sight Medical Products
EYES
|
16.2 M | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
82 M | $ 9.84 | -19.05 % | $ 390 M | ||
|
Sintx Technologies
SINT
|
4.14 M | $ 2.21 | -0.23 % | $ 6.13 M | ||
|
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
526 M | $ 82.51 | -1.79 % | $ 11.2 B | ||
|
Insulet Corporation
PODD
|
716 M | $ 154.31 | -1.46 % | $ 10.9 B | ||
|
TransMedics Group
TMDX
|
488 M | $ 65.7 | -3.38 % | $ 2.23 B | ||
|
CONMED Corporation
CNMD
|
40.8 M | $ 35.91 | -3.01 % | $ 1.11 B | ||
|
Inspire Medical Systems
INSP
|
105 M | $ 43.44 | -1.61 % | $ 1.28 B | ||
|
Integer Holdings Corporation
ITGR
|
17.2 M | $ 89.46 | -2.15 % | $ 3.11 B | ||
|
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
2.94 B | $ 82.31 | -0.82 % | $ 48.1 B |